You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

1504 Results
Document
May 2022
Document
Jun 2022
Document
Jun 2022
Document
Jun 2022
Document
Jun 2022
Document
Jun 2022
Document
Jun 2022
Document
Jun 2022
Document
Jun 2022
Document
Jun 2022
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Drugs Used:
riTUXimab (Unfunded),
methotrexate,
cytarabine,
thiotepa (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Apr 2024
Document
Jun 2022

Pages